RAPT Therapeutics · 1 day ago
Clinical Trial Manager
RAPT Therapeutics is a company focused on clinical research, and they are seeking a Clinical Trial Manager to oversee day-to-day clinical operations for their trials. The role involves collaborating with various teams to ensure high-quality data delivery while adhering to regulatory standards and managing vendor relationships.
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Responsibilities
Supports/Leads the set-up and on-time execution of clinical study tasks, while ensuring the trial is conducted to RAPT quality standards and in compliance with the protocol, SOPs, ICH-GCP, and applicable regulatory requirements
Collaborates with cross-functional teams to ensure effective delivery of the assigned activities to meet project milestones
Supports/Leads identification, selection, contracting and management of study vendors/CROs and development of vendor scope of work (SOW)
Supports/Leads the development and review of clinical study plans (Clinical Monitoring Plans, Data Management Plans, Safety Management Plans, Communication Plans, etc.), and other project/study-related documents including training materials, forms, logs, presentations, etc
Acts as primary point of contact for assigned trial(s) for vendors, partners, investigational sites, and RAPT internal teams
Participates in specification development, design, set-up and UAT of trial infra-structure systems (EDC, IRT, CTMS, eCOA, etc.)
As needed, works closely with RAPT Biomarker Team staff and external personnel (Central Labs, specialty labs, clinical trial study sites, etc.) on clinical laboratory activities including specimen management & logistics, data management, and issue identification and resolution
Collaborates with RAPT Clinical Drug Supply Manager and internal and external CMC / Supply Chain personnel to forecast investigational product needs and identify distribution, storage, and accountability requirements
Collaborates with RAPT Clinical Project Manager and Finance personnel to ensure accuracy and financial information related to clinical trial progress, including enrollment information, timeline status, and budget forecasts and updates
Writes/Contributes to clinical trial protocols and protocol-associated documents including Informed Consent Forms and other documents as needed or requested
Coordinates/Performs in-house review of clinical data listings for completeness and accuracy and escalates issues to the vendor and RAPT internal team, as needed
Manages clinical monitoring activities, overall site performance, and ensures compliance with Good Clinical Practices (GCP) and applicable regulations
Reviews monitoring trip reports, ensures follow-up of action items to resolution and escalates critical issues and risks, as necessary
Responsible for ongoing review/oversight of TMF and other records as assigned
Organizes and manages internal team meetings, investigator meetings, and other trial-specific meetings as required
Other duties as assigned
Develop and maintain strong internal and external relationships with key stakeholders
Lead the team when making decisions/recommendations that require cross-functional input and that have cross-functional implications
Effectively communicate with key stakeholders at all levels of the organization
Quickly and accurately identify issues and propose and implement effective solutions
Prospectively identify risks and mitigation approaches, and implement them as appropriate
Qualification
Required
Bachelor's degree required, preferably in a scientific discipline
Minimum of 2 years of clinical operations experience
Ability to work on-site at our South San Francisco office 3 days per week
Preferred
Advanced degree preferred
Recent experience managing ex-US sites on a Global Clinical Trial is desired
The ideal candidate will have recent experience managing clinical trial(s) in immunology and/or dermatology
Experience directly managing clinical vendors, including CRO, eCOA, etc
Company
RAPT Therapeutics
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
Funding
Current Stage
Public CompanyTotal Funding
$840.2MKey Investors
The Column GroupRedmile Group
2025-10-21Post Ipo Equity· $250M
2024-12-23Post Ipo Equity· $150M
2022-11-17Post Ipo Equity· $70.5M
Recent News
2025-11-28
DelveInsight Business Research LLP
2025-11-10
2025-11-08
Company data provided by crunchbase